Diagnostics &
Monitoring
Transforming neurological care through AI-powered behavioral biomarkers. We provide the tools for earlier detection and precise monitoring of Parkinson's Disease.
Technology Highlight
Quamon-PD™ : Multi-modal quantitative system
Powered by proprietary computer vision and deep learning algorithms trained on verified clinical datasets.
Quamon-PD™
Our flagship clinical monitoring application uses advanced AI to analyze behavioral data for early detection and progression monitoring of Parkinson’s Disease and related disorders. By replacing subjective clinical observation with quantitative multi-modal data, Quamon-PD™ provides comprehensive, evidence-based reports for healthcare providers.
Key Features
- Multi-modal data analysis (gait, speech, decision making, tremor)
- Early detection algorithms using ML biomarkers
- Comprehensive clinical reports with percentile scoring
- Seamless integration with EHR and clinical workflows
Clinical Applications
- Early-stage Parkinson's (PD) detection
- Disease progression monitoring & staging
- Evaluation of treatment/medication response
- Clinical research and data-driven drug trials
Advance Your Clinical Precision
Neurogati's clinical monitoring tools are designed to work within existing medical infrastructures to provide objective data for complex decisions.